Medicamentos Oncologicos - Readjudicada en Id 2130-460-R212
EL ABASTECIMIENTO DE MEDICAMENTOS PARA CUBRIR LA DEMANDA PROGRAMADA DE SECCION FARMACIA
23 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 2130-2002-SE13 | 25-02-2013 | Laboratorios Rider Limitada | $710.430 |
| 2130-2011-SE13 | 25-02-2013 | Tecnofarma S.A. | $449.820 |
| 2130-1990-SE13 | 25-02-2013 | Industrial y Comercial Baxter de Chile Limitada | $8.925 |
| 2130-2003-SE13 | 25-02-2013 | Novartis Chile S.A. | $296.072 |
| 2130-1987-SE13 | 25-02-2013 | Astrazeneca S.A. | $2.550.170 |
| 2130-1552-SE13 | 11-02-2013 | Laboratorios Rider Limitada | $260.491 |
| 2130-1125-SE13 | 30-01-2013 | Laboratorios Rider Limitada | $236.810 |
| 2130-793-SE13 | 23-01-2013 | Astrazeneca S.A. | $2.550.170 |
| 2130-786-SE13 | 23-01-2013 | Tecnofarma S.A. | $224.910 |
| 2130-787-SE13 | 23-01-2013 | Productos Farmoquimicos Roche Limitada | $1.567.825 |
| 2130-792-SE13 | 23-01-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $3.752.070 |
| 2130-11783-SE12 | 31-12-2012 | Socofar S.A. | $589.050 |
| 2130-11759-SE12 | 31-12-2012 | Astrazeneca S.A. | $2.550.170 |
| 2130-11762-SE12 | 31-12-2012 | Glaxosmithkline Chile Farmaceutica Limitada | $3.752.070 |
| 2130-11767-SE12 | 31-12-2012 | Laboratorios Rider Limitada | $236.810 |
| 2130-11777-SE12 | 31-12-2012 | Novartis Chile S.A. | $12.789.361 |
| 2130-11779-SE12 | 31-12-2012 | Productos Farmoquimicos Roche Limitada | $1.567.825 |
| 2130-11782-SE12 | 31-12-2012 | Tecnofarma S.A. | $374.850 |
| 2130-11060-SE12 | 10-12-2012 | Laboratorios Kampar S.A. | $190.400 |
| 2130-10560-SE12 | 27-11-2012 | Tecnofarma S.A. | $524.790 |
| 2130-10535-SE12 | 27-11-2012 | Astrazeneca S.A. | $1.275.085 |
| 2130-10538-SE12 | 27-11-2012 | Industrial y Comercial Baxter de Chile Limitada | $82.646 |
| 2130-10546-SE12 | 27-11-2012 | Laboratorios Rider Limitada | $236.810 |
| 2130-10547-SE12 | 27-11-2012 | Novartis Chile S.A. | $11.709.142 |
| 2130-10557-SE12 | 27-11-2012 | Socofar S.A. | $353.430 |
| 2130-9292-SE12 | 23-10-2012 | Tecnofarma S.A. | $466.480 |
| 2130-9270-SE12 | 23-10-2012 | Astrazeneca S.A. | $1.530.102 |
| 2130-9276-SE12 | 23-10-2012 | Laboratorios Recalcine S.A. | $5.140.800 |
| 2130-9278-SE12 | 23-10-2012 | Laboratorios Rider Limitada | $236.810 |
| 2130-9282-SE12 | 23-10-2012 | Novartis Chile S.A. | $15.308.833 |
| 2130-9291-SE12 | 23-10-2012 | Socofar S.A. | $294.525 |
| 2130-9066-SE12 | 16-10-2012 | Laboratorios Rider Limitada | $213.129 |
| 2130-8190-SE12 | 21-09-2012 | Astrazeneca S.A. | $5.100.340 |
| 2130-8191-SE12 | 21-09-2012 | Laboratorios Rider Limitada | $196.350 |
| 2130-7872-SE12 | 07-09-2012 | Pfizer Chile S.A. | $3.942.708 |
| 2130-3223-SE12 | 23-08-2012 | Astrazeneca S.A. | $2.040.136 |
| 2130-7215-SE12 | 22-08-2012 | Pfizer Chile S.A. | $11.031.300 |
| 2130-6173-SE12 | 25-07-2012 | Industrial y Comercial Baxter de Chile Limitada | $35.700 |
| 2130-3217-SE12 | 30-05-2012 | Pfizer Chile S.A. | $1.469.174 |
| 2130-3220-SE12 | 30-05-2012 | Laboratorios Rider Limitada | $714.000 |
| 2130-3221-SE12 | 08-05-2012 | Laboratorio Chile S.A. | $658.365 |
| 2130-3213-SE12 | 26-04-2012 | Socofar S.A. | $942.480 |
| 2130-3214-SE12 | 26-04-2012 | Laboratorios Kampar S.A. | $827.050 |
| 2130-3215-SE12 | 26-04-2012 | Tecnofarma S.A. | $871.080 |
| 2130-3216-SE12 | 26-04-2012 | Novartis Chile S.A. | $16.311.348 |
| 2130-3218-SE12 | 26-04-2012 | Glaxosmithkline Chile Farmaceutica Limitada | $3.126.725 |
| 2130-3219-SE12 | 26-04-2012 | Laboratorios Recalcine S.A. | $3.694.950 |
| 2130-3222-SE12 | 26-04-2012 | Productos Farmoquimicos Roche Limitada | $3.392.333 |
| 2130-3224-SE12 | 26-04-2012 | Industrial y Comercial Baxter de Chile Limitada | $35.700 |
Fuente original:ficha mercadopublico.cl
